Medical Immunology

January 29, 2018 | Author: Anonymous | Category: Science, Health Science, Immunology
Share Embed Donate


Short Description

Download Medical Immunology...

Description

Medical Immunology Department of Immunology

Yiwei Chu 储以微 [email protected]

2010-7-7

Exam: 9th July (Friday) 8:30-10:30am

Inspector: Dr. Lu Qing Dr. Gao Bao

2010-7-7

Department of Immunology Yiwei Chu

Wei Xu

Rui He

Yunlu Lin Qing Lu

Xiaowu Hong

Bo Gao

Haifeng Gao

Define of Immunology

IMMUNITY ---protection from disease (infectious disease) IMMUNE SYSTEM --- organ, cell, molecule and gene IMMUNE RESPNSE --- response to the foreign substances

Define of Immunology

IMMUNE FUNCTIONS ---immune defence (infectious disease)

--- immune surveillance

--- immune homeostasis

Define of Immunology

IMMUNITY ---protection from disease (infectious disease) IMMUNE SYSTEM --- organ, cell, molecule and gene IMMUNE RESPNSE --- response to the foreign substances

Innate and Adaptive Immunity

Adaptive Immune Responses

Adaptive Immune Responses Cellular Components

• Lymphocytes - B, Th, CTL, NKT

• Antigen-presenting cells(APCs) - DC, Mj, B

• Effector cells - Activated T cells, mononuclear phagocytes

Basic Immunology

Recognition

Activation

Effection

Ag (antigen)

double recognition humural immunity

APC

double signaling

(antigen presenting cell)

cellular immunity

Chapter 1 Definition of antigen Antigen (Ag) Substances that combine specifically with a B or T cell’s antigen-binding

receptors can then induce an immune response are called

antigens.

Chapter 2 Characteristics of antigen The antigen molecule generally pose two natures, that is (1)immunogenicity (2)antigenicity

(1) Antigenic determinants or epitopes Antigenic determinants or epitopes are the

immunologically active regions of an immunogen that bind to antigen-specific membrane receptors on lymphocytes (TCR/BCR) or to secreted antibodies.

Structure of epitopes 1 Conformational epitope

Nonsequential polypeptides or polysaccharide on the

surface of the molecules, Native conformation,

2 liner epitope

A sequential amino acid fragment, Linear determinant,

Inside of the antigen molecule

(3) hypervarible region (HVR) (complimentarity determining region,

CDR) :

formation of the Ag binding site Framework region( FR ) : maintaining the 3- dimensional configuration

CDR

(complimentarity determining region,)

4. Ab-dependent Cell-mediated cytotoxicity, ADCC enhance NK killing

Immune Responses to Tumors

CONCEPT

APCs are immunocytes that can uptake, process and present antigens to other lymphocytes.

Professional APCs Dendritic Cells (DCs) Macrophages (M) B Lymphocytes

I. Dendritic Cells (DCs)

Ralph.M.Steinman, 1973

The invariant chain is cleaved to leave a peptide fragment, CLIP, bound to the MHC class II molecule CLIP (class II-associated invariant-chain peptide)

MHC class II molecule combined with peptide

What are cytokines?  Cytokines are polypeptides produced by the cells of innate and adaptive immunity in response to microbes and other antigens as a result of cellular activation.  Cytokines initiate their actions by binding to specific membrane receptors on target cells. The cellular responses to most cytokines consist of gene activation, resulting in the expression of new functions and sometimes the proliferation of the target cells

Cytokine actions may be local and systemic

Autocrine action

Paracrine action

act on cytokine-producing cell itself

act on a nearby cell

circulation

Endocrine action

act at a distance from the site of infection

Chemokines Primary lymphoid organs

Secondary lymphoid organs

directing migration of leukocytes Blood

Tissue

inflammation

Cellular sources (1) inflammatory stimuli

to inflammatory sites

(2) Constitutively produced in lymphoid organs Physiologic traffic of lymphocytes through the organs

IL-2 • a growth factor for antigen-stimulated T lymphocytes • responsible for T cell clonal expansion after antigen recognition

Natural Killer cells (NK cells)  A type of cytotoxic lymphocytes  The principal physiologic role 1.

Defense against infections by viruses and some other intracelluar microbes

2. Rejection of tumors

The mechanism of effector function

Perforin

Granzyme

Pathogen-associated molecular patterns (PAMPs)  Small molecular motifs conserved within a class of microbes

 Usually essential for survival of the microbes  Recognized by cells of innate immune system  Activate innate immune response

Examples of PAMPs PAMPs

Source

Principle innate immune response

LPS

Gram-negative bacteria cell wall

Macrophage activation

dsRNA

Replicating viruses

Type I IFN production by infected cells

Unmethylated CpG DNA

Bacterial DNA

Macrophage activation

N-formylmethionine

Bacteria protein

neutrophil and macrophage activation

Mannose-rich glycans

Microbial glycoproteins or glycolipid

phgocytosis opsonization complement activation

Patterns recognition receptors (PRRs)  Proteins expressed by cells of innate immune system  Present on the cell surface, in endosomal vesicles, and in the cytoplasm

The subsets of CD4+Th cells

 How they are induced,  What cytokines they produce  What effector mechanisms they activate

Development of Th1 and Th2 subsets

Surface receptor 1) B cell antigen receotor (BCR) BCR/mIgM Membrane Ig (mIg) Mature B cell: mIgM + mIgD

BCR-Igα/Igβ complex

BCR-Iga/Igb complex

2. BCR coreceptor Help and strengthen the BCR-Ag-signaling CD19 B-specific surface marker

signal transduction CD21 CR2,receptor for C3d-bound Ag CD81 BCR-coreceptor ligation induce reversible palmitoylation of CD81 to stabilize the CD19/CD21/CD81 complex

JBC 2004;279:31973

BCR-Iga/Igb coreceptor complex B cell epitope

B cell activation

TCR-CD3

BCR-Iga/b

Two-signal activation model for T cells

activation

co-stimulatory molecules none

naive

anergy

Two-signal activation model for B cells

Signal 1 and signal 2 are not simultaneous But in two steps, signal 2 from Th cells

Signal 3

MZ B cells

innate immune functions

B-1 cells (peritoneal cavity) marginal zone (MZ) B cells (spleen)

frequent Ag encounter. Secreting essentially germline-encoded, polyreactive natural Abs, respond rapidly and vigorously to pathogens express Toll-like receptors (TLR), provide costimulation to GC B cells important link between the innate and adaptive immunity

B1

B2/FO B

location

mucosal sites

spleen, LN

Ig-producing way

naturally

Ag-inductive

specificity

poly-reactive

highly specific

Ag

TI Ag

TD Ag

(polysaccharide)

Ig class

Ig M

IgG

affinity

low

high

Significance of humoral immunity eliminate extracellular bacterium and toxin eliminate extracellular virus

Antigen crosslinks mIg(BCR), generating signal 1, which leads to increased expression of class II MHC and costimulatory B7. Antigen–BCR complexes are internalized by receptor-mediated endocytosis and degraded to peptides, which are bound by class II MHC and presented as peptide–MHC complexes. Th cell recognizes Ag–class II MHC and B7-CD28 co-stimulation on Bcell membrane which activates TH cell. Th cell begins to express CD40L. Interaction of CD40 and CD40L provides signal 2.

Th cell release large quantities of cytokines(IL-4) signal 3 to support the progression of the B cell replication and differentiation.

Early and late event in Ab response to TD antigen

Early events: follicle(B)-paracortex(T)border,

B activation and T-B activation Small amounts of Ab production

Late events: At the germinal center Presence of Ag and Th

Affinity maturation Ig class switch (IgM Memory B

IgG)

General Features and Mechanisms  Immunologically specific  Central tolerance: induced in generative lymphoid organs immature self-reactive lymphocyte The repertoire of mature lymphocytes cannotcannot recognize ubiquitousubiquitous or widely repertoire of mature lymphocytes recognize disseminated self antigens self antigens or widely disseminated

T Lymphocyte Tolerance  Central T Cell Tolerance  Peripheral T cell Tolerance

Burnet: Clonal selection hypothesis

Peripheral T cell Tolerance     

Antigen recognition without adequate costimulation Use CTLA-4 to recognize costimulators on APCs Activation induced cell death (AICD) Regulatory T Lymphocytes Factors that determine the tolerogenicity of self antigens

Tumor Antigen •

Tumor-specific antigen Antigen that are expressed on tumor cells but not on normal cells were called tumor- specific antigens; some of these antigens are unique to individual tumors, whereas others are shared among tumors of the same type.

Tumor Antigen •

Tumor-associated antigen Tumor antigens that are also expressed on normal cells were called

tumor-associated antigens; in most cases, these antigens are normal cellular constituents whose expression is aberrant or

dysregulated in tumors

Evasion of Immune Responses  Class I MHC expression may be down-regulated on tumor cells so that they cannot be recognized by CTLs.  Tumor lose expression of antigen that elicit immune responses.

 Tumors may fail to induce CTLs because most tumor cells do not express costimulators or class II MHC molecules.  The products of tumor cells may suppress antitumor immune responses.  Tumor antigens may induces may induce specific immunologic tolerance.

Difference between Direct Recognition and Indirect Recognition Direct Recognition

Indirect Recognition

Allogeneic MHC molecule

Intact allogeneic MHC molecule

Peptide of allogeneic MHC molecule

APCs

Recipient APCs are not necessary

Recipient APCs

Roles in rejection

Acute rejection

Chronic rejection

Degree of rejection

Vigorous

Weak

57

Classification of Allograft Rejection

Host versus graft reaction (HVGR) Conventional organ transplantation

Graft versus host reaction (GVHR) Bone marrow transplantation Immune cells transplantation

58

II.Graft versus host reaction (GVHR) Conditions

Enough immune competent cells in grafts Immunocompromised host Histocompatability between host and graft

differences

59

Hypersensitivity Tissue injury caused by an immune response that is inadequately controlled or inappropriately targeted to host tissues

Types of hypersensitivity reactions

GELL AND COOMB’S CLASSIFICATION

Type I: Type II: Type III: Type IV:

Immediate Cytotoxic Immune complex cell mediated or delayed

THANK YOU

View more...

Comments

Copyright � 2017 NANOPDF Inc.
SUPPORT NANOPDF